[Prospects of short-term sequential immunomodulation with levamisole and Corynebacterium parvum in neoplastic pathology in the aged].
D000368:Aged; D001799:Blood Sedimentation; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007167:Immunotherapy / Q000379:methods*; D007958:Leukocyte Count; D007978:Levamisole / Q000627:therapeutic use*; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D009088:Mucoproteins / Q000097:blood; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D011425:Propionibacterium acnes
D007136:Immunoglobulins; D009088:Mucoproteins; D007978:Levamisole; D005340:Fibrinogen; D003165:Complement System Proteins
Prospettive di immunomodulazione sequenziale a breve termine con levamisolo e Corinebacterium parvum nella patologia neoplastica dell'anziano.